Earlier this month, Novo Nordisk said it expects continued competition from copycat version Wegovy this year and rising pressure from main U.S. rival, Eli Lilly
Read More Novo Nordisk to offer Ozempic at $499 per month to eligible US customersTag: Semaglutide
Ozempic copies restricted after US judge denies injunction
A U.S. judge rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk’s popular drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds.
Read More Ozempic copies restricted after US judge denies injunctionThe Significance Of The Trump-RFK Healthcare Revolution
By Rick Amato
November 14, 2024
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
Read More The Significance Of The Trump-RFK Healthcare Revolution

 
					 
					